Natco Pharma Ltd. - Research Center
524816 NATCOPHARM Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 2,351.00 | 1,767.80 | 1,653.50 | 1,790.20 | 1,986.30 |
| Expenses | |||||
| Material consumed | 567.10 | 570.10 | 528.10 | 426.00 | 376.30 |
| Manufacturing expenses | 81.90 | 76.40 | 59.40 | 62.40 | 59.60 |
| Personnel expenses | 425.70 | 410.10 | 380.00 | 356.10 | 340.20 |
| Selling expenses | - | - | - | - | - |
| Adminstrative expenses | 431.60 | 498.20 | 268.40 | 367.70 | 393.70 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 1,506.30 | 1,554.80 | 1,235.90 | 1,212.20 | 1,169.80 |
| Operating profit | 844.70 | 213.00 | 417.60 | 578.00 | 816.50 |
| Other recurring income | 85.50 | 94.60 | 101.10 | 123.80 | 129.80 |
| Adjusted PBDIT | 930.20 | 307.60 | 518.70 | 701.80 | 946.30 |
| Financial expenses | 8.60 | 13.30 | 11.30 | 20.60 | 18.80 |
| Depreciation | 150.90 | 138.40 | 115.20 | 98.10 | 80.10 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 770.70 | 155.90 | 392.20 | 583.10 | 847.40 |
| Tax charges | 133.60 | 16.80 | 82.70 | 108.60 | 180.30 |
| Adjusted PAT | 637.10 | 139.10 | 309.50 | 474.50 | 667.10 |
| Non recurring items | 1.70 | 9.80 | -0.30 | -5.20 | - |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 638.80 | 148.90 | 309.20 | 469.30 | 667.10 |
| Earnigs before appropriation | 3,225.90 | 2,668.90 | 2,631.70 | 2,476.10 | 2,138.00 |
| Equity dividend | 100.40 | 82.10 | 113.90 | 101.20 | 73.00 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | 26.20 | 18.90 |
| Retained earnings | 3,125.50 | 2,586.80 | 2,517.80 | 2,348.70 | 2,046.10 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis